The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza a virus and dengue virus replication

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 7837-7852

  John, Sinu P ^a,b,i   Chin, Christopher R ^a   Perreira, Jill M ^a   Feeley, Eric M ^b   Aker, Aaron M ^a   Savidis, George ^a   Smith, Sarah E ^c   Elia, Andrew E H ^d,e,f   Everitt, Aaron R ^c   Vora, Mehul ^a   Pertel, Thomas ^b   Elledge, Stephen J ^d,e,g   Kellam, Paul ^c,h   Brassa, Abraham L ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h MEDICAL RESEARCH COUNCIL   (United Kingdom)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DENGUE; IN VITRO STUDY; INFLUENZA A; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CELL CULTURE TECHNIQUES; CLONING, MOLECULAR; CONSERVED SEQUENCE; DENGUE VIRUS; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DOGS; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEINS; VIRUS REPLICATION;

EID: 84880297659     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00481-13     Document Type: Article

References (30)

1. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254.
2. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M. 2011. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenzaAvirus. PLoS Pathog. 7:e1001258. doi:10.1371/journal.ppat.1001258.
3. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, Zhang X, Birk A, Chang J, Shi PY, Block TM, Guo JT. 2010. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84:8332-8341.
4. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
5. Lu J, Pan Q, Rong L, Liu SL, Liang C. 2011. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85:2126-2137.
6. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267.
7. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P. 2012. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484:519-523.
8. Wakim LM, Gupta N, Mintern JD, Villadangos JA. 2013. Enhanced survival of lung tissue-resident memory CD8() T cells during infection with influenza virus due to selective expression of IFITM3. Nat. Immunol. 14:238-245.
9. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, Wang DY, Shu YL, Ho LP, Kellam P, McMichael A, Dong T. 2013. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat. Commun. 4:1018. doi:10.1038/ncomms2433.
10. Yount JS, Karssemeijer RA, Hang HC. 2012. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 287:19631-19641.
11. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A, Finn RD. 2012. The Pfam protein families database. Nucleic Acids Res. 40:D290-D301.
12. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL. 2011. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 7:e1002337. doi:10.1371/journal.ppat.1002337.
13. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT. 2010. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84: 12646-12657.
14. Biechler SV, Potts JD, Yost MJ, Junor L, Goodwin RL, Weidner JW. 2010. Mathematical modeling of flow-generated forces in an in vitro system of cardiac valve development. Ann. Biomed. Eng. 38:109-117.
15. Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, Lopez CB, Hang HC. 2010. Palmitoylome profiling reveals S-palmitoylationdependent antiviral activity of IFITM3. Nat. Chem. Biol. 6:610-614.
16. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-926.
17. Gu TL, Deng X, Huang F, Tucker M, Crosby K, Rimkunas V, Wang Y, Deng G, Zhu L, Tan Z, Hu Y, Wu C, Nardone J, MacNeill J, Ren J, Reeves C, Innocenti G, Norris B, Yuan J, Yu J, Haack H, Shen B, Peng C, Li H, Zhou X, Liu X, Rush J, Comb MJ. 2011. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6:e15640. doi:10.1371/journal.pone.0015640.
18. Thingholm TE, Larsen MR, Ingrell CR, Kassem M, Jensen ON. 2008. TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment. J. Proteome Res. 7:3304-3313.
19. Choudhary C, Olsen JV, Brandts C, Cox J, Reddy PN, Bohmer FD, Gerke V, Schmidt-Arras DE, Berdel WE, Muller-Tidow C, Mann M, Serve H. 2009. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol. Cell 36:326-339.
20. Mertins P, Eberl HC, Renkawitz J, Olsen JV, Tremblay ML, Mann M, Ullrich A, Daub H. 2008. Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics. Mol. Cell. Proteomics 7:1763-1777.
21. Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, Qiao W, Liang C. 2012. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J. Virol. 86:13697-13707.
22. Greaves J, Chamberlain LH. 2007. Palmitoylation-dependent protein sorting. J. Cell Biol. 176:249-254.
23. Chen WJ, Goldstein JL, Brown MS. 1990. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265:3116-3123.
24. Boucrot E, Pick A, Camdere G, Liska N, Evergren E, McMahon HT, Kozlov MM. 2012. Membrane fission is promoted by insertion of amphipathic helices and is restricted by crescent BAR domains. Cell 149:124-136.
25. Brown MF. 2012. Curvature forces in membrane lipid-protein interactions. Biochemistry 51:9782-9795.
26. Callan-Jones A, Bassereau P. 2012. Membrane fission: curvaturesensitive proteins cut it both ways. Dev. Cell 22:691-692.
27. Hurley JH. 2006. Membrane binding domains. Biochim. Biophys. Acta 1761:805-811.
28. Ivanovic T, Choi JL, Whelan SP, van Oijen AM, Harrison SC. 2013. Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. eLife 2:e00333. doi:10.7554/eLife.00333.
29. Harrison SC. 2008. Viral membrane fusion. Nat. Struct. Mol. Biol. 15: 690-698.
30. Nikolaus J, Herrmann A. 2012. Functional relevance of transmembrane domains in membrane fusion. Biol. Chem. 393:1231-1245.